Kosh Agarwal - Dissemin

Papers authored by Kosh Agarwal

This paper is made freely available by the publisher.

2019 Bo Wang, Ghulam Mufti, Kosh Agarwal

Reactivation of hepatitis B virus infection in patients with hematologic disorders

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Alice Russell, Nilay Hepgul

, Naghmeh Nikkheslat

, Alessandra Borsini

, Zuzanna Zajkowska, Natalie Moll, Daniel Forton, Kosh Agarwal

, Trudie Chalder

, Valeria Mondelli

, Matthew Hotopf, Anthony Cleare

, Gabrielle Murphy, Graham Foster, Terry Wong and 5 other authors

Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome

Upload

Eric Lawitz, Edward Gane, Eric Cohen, John Vierling, Kosh Agarwal

, Tarek Hassanein, Parvez S. Mantry, Paul J. Pockros, Michael Bennett, Nyingi Kemmer, Giuseppe Morelli, Jiuhong Zha, Deli Wang, Nancy S. Shulman, Daniel E. Cohen and 1 other authors

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Christiana Moigboi, Ivana Carey, Sanjay Bansal, Kosh Agarwal

, Diego Vergani, Giorgina Mieli-Vergani

Clinical Utility of HBV Serology and Virology Markers in Childhood for Assessing Liver Disease Progression Between Childhood and Adulthood

Upload

Ruth Byrne, Mary Horner, Matthew Bruce, Jeffrey Gersch, Mary Kuhns, Gavin Cloherty, Kosh Agarwal

, Ivana Carey

Serum HBV RNA as a predictor of incomplete HBV DNA suppression following initiation of nucleoside therapy inHBV/HIV co-infected individuals

Upload

Mark S. Sulkowski, Mark S. Sulkowski, Kosh Agarwal

, Kosh Agarwal, Scott K. Fung, Scott K. Fung, Man-Fung Yuen, Man-Fung Yuen, Xiaoli Ma, Xiaoli Ma, Jacob P. Lalezari, Jacob P. Lalezari, Tuan T. Nguyen, Tuan T. Nguyen, Ho S. Bae and 53 other authors

CONTINUED THERAPY WITH ABI-H0731+NRTI RESULTS IN SEQUENTIAL REDUCTION/LOSS OF HBV DNA, HBV RNA, HBeAg, HBcrAg AND HBsAg IN HBeAg POSITIVE PATIENTS

Upload

Pietro Lampertico, Maria Buti, Scott Fung, Sang Hoon Ahn, Wan-Long Chuang, Won Young Tak, Alnoor Ramji, Chi-Yi Chen, Edward Tam, Ho Bae, Xiaoli Ma, John F. Flaherty, Anuj Gaggar, Audrey Lau, Becket Feierbach and 9 other authors

A Phase 3 Study Comparing Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide With Continued TDF Treatment in Virologically Suppressed Patients With Chronic Hepatitis B: Week 48 Efficacy and Safety Results

Upload

Efficacy and Safety Results 48 Weeks After Switching From Tenofovir Disoproxil Fumarate (Tdf) to Tenofovir Alafenamide (Taf) vs Continued TDF Treatment in Virologically-Suppressed Patients With Chronic Hepatitis B (Chb)

Upload

J. Nayagam, O. Tavabie, B. Norton, W. Jassem, N. Heaton, K. Menon, W. Bernal, D. Joshi, A. Suddle, J. O'Grady, K. Agarwal

, M. Heneghan, Aluvihare

Chronic kidney disease in liver transplantation - even early stage disease is associated with post operative renal replacement therapy

Upload

Stuart Flanagan, Jan Kunkel, Victoria Appleby, Sandra E. Eldridge, Sharif Ismail

, Sulleman Moreea, Christopher Griffiths, Robert Walton, Martin Pitt, Andrew Salmon, Vicithranie Madurasinghe, Eleanor Barnes, Elizabeth Simms, Kosh Agarwal

, Graham R. Foster

Case finding and therapy for chronic viral hepatitis in primary care (HepFREE): a cluster-randomised controlled trial

Upload

Henry Lik Yuen Chan, Henry Lik Yuen Chan, Pietro Lampertico, Pietro Lampertico, Sang Hoon Ahn, Sang Hoon Ahn, Scott K. Fung, Scott K. Fung, Ho S. Bae, Ho S. Bae, Alnoor Ramji, Alnoor Ramji, June Sung Lee, June Sung Lee, Stephen David Shafran and 25 other authors

Impact of Prior Tenofovir Disoproxil Fumarate (Tdf) Treatment Duration on Tenofovir Alafenamide (Taf) Safety Profile in Virally Suppressed Chronic HBV Patients Switched From TDF to Taf

Upload

Man-Fung Yuen, Rozalina Ivanova Balabanska, Kosh Agarwal

, Yonghong Zhu, Joseph Grippo, Yuyan Jin, Qiudi Jiang, Miriam Triyatni, Ruchi Upmanyu, Katerina Glavini, Tomas Racek, Edward J. Gane

Safety, Pharmacokinetic, Pharmacodynamic and Viral Data After 6-Weeks of Dosing With Tlr7 Agonist Ro7020531 in Chronic Hepatitis B Patients

Upload

Christiana Moigboi, Matthew Bruce, Mary Horner, Geoffrey Dusheiko, Kosh Agarwal

, Ivana Carey

Is the performance of ultra-sensitive HBsAg Fujirebio assay consistent across HBV genotypes (comparison between CLEIA HBsAg HQ Fujirebio and Abbott Architect assays)

Upload

Aisling Considine, Sital Shah, Helen Boothman, Kosh Agarwal

, Kathryn Childs, Mary Cannon

Sequential Treatment Failure in Patients With HCV and Hcc: Time to Rethink the Retreatment Regimen?

Upload

Harry L. A. Janssen, Young-Suk Lim, Edward J. Gane, Claire Fournier, Sang Hoon Ahn, Owen Tsang, Wan Long Chuang, Jeong Heo, Aric Josun Hui, Magdy Elkhashab, Chi-Yi Chen, Wei-Wen Su, John F. Flaherty, Anuj Gaggar, Susanna Tan and 10 other authors

Efficacy and Safety of Switching to Tenofovir Alafenamide (Taf) in Virally Suppressed Chronic Hepatitis B (Chb) Patients With Renal Impairment: Week 24 Results From a Phase 2 Open-Label Study

Upload

Maria Buti, Pietro Lampertico, Young-Suk Lim, Kosh Agarwal

, Scott K. Fung, Owen Tsang, Magdy Elkhashab, Jia-Horng Kao, Jose Luis Calleja, Mandana Khalili, Natarajan Ravendhran, Susanna Tan, John F. Flaherty, Anuj Gaggar, Audrey H. Lau and 6 other authors

Safety and Efficacy at 48 Weeks After Switching From Tenofovir Disoproxil Fumarate (Tdf) to Tenofovir Alafenamide (Taf) in Chronic HBV Patients With Risk Factors for TDF Use

Upload

Ira M. Jacobson, Andrew J. Muir, Eric J. Lawitz, Edward J. Gane, Brian Conway, Peter J. Ruane, Ziad Younes, Frances Chen, Marianne Camargo, Anand Chokkalingam, Stephen Djedjos, Anuj Gaggar, Robert P. Myers, Barbara A. Leggett, Jose Luis Calleja and 3 other authors

Course of Cirrhosis Regression: Lessons From Patients With HCV Cirrhosis Following Successful Sofosbuvir-Based Treatment

Upload

Zachary Schwartz, Jenny Schulz, Edward King, Kosh Agarwal

, Grace L. Wong, Paul Yien Kwo

Hep B Consult: A Point-of-Care Interactive Decision Support Tool Delivers Real-Time, Personalized, Guideline-Based Teaching and Reveals Variance Between Clinicians and Guidelines in the Management of HBV Infection

Upload

Ali Jibran Mecci, Polychronis Kemos, Clifford Leen, Adam Lawson, Paul Richardson, Salim I. Khakoo, Kosh Agarwal

, David Mutimer, William M. Rosenberg, Graham R. Foster, William L. Irving, K. Agarwal, M. Aldersley, A. Ali, S. Aravamuthan and 20 other authors

The association between hepatocellular carcinoma and direct-acting anti-viral treatment in patients with decompensated cirrhosis

Upload

Charlotte Hedskog, Silvia Chang, Bandita Parhy, Dara Burdette, Ondrej Podlaha, Wan-Long Chuang, Kosh Agarwal

, Edward Gane, Anuj Gaggar, Simon Fletcher, Hongmei Mo

HBV splice DNA forms detected in serum in majority of patients with chronic HBV infection

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Kosh Agarwal